Literature DB >> 2286024

Light microscopic and ultrastructural study on CNS lesions in infantile Gaucher's disease.

J Cervos-Navarro1, C Zimmer.   

Abstract

We report on the light microscopic and ultrastructural CNS findings and the clinical course in a boy with infantile Gaucher's disease who died at 6 1/2 months. Besides the morphological alterations described in the literature, like perivascular Gaucher cells and nerve cell loss, our case was characterized by an unusually extensive proliferation of GFAP-positive astrocytes in the vicinity of stored material but also in regions where no storage was detected. Electron microscopy revealed massively enlarged lysosomes in the storage cells. The lysosomes showed twisted tubular structures, some of them penetrating the outer membrane. Isolated tubules were found to lie free in the cytosol. These tubules correspond to stored crystallized glucocerebroside molecules, which are most stable in this twisted arrangement.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2286024

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  8 in total

1.  The increased sensitivity of neurons with elevated glucocerebroside to neurotoxic agents can be reversed by imiglucerase.

Authors:  D Pelled; H Shogomori; A H Futerman
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

Review 2.  Type 2 Gaucher disease: phenotypic variation and genotypic heterogeneity.

Authors:  N Gupta; I M Oppenheim; E F Kauvar; N Tayebi; E Sidransky
Journal:  Blood Cells Mol Dis       Date:  2010-09-28       Impact factor: 3.039

3.  Glucosylceramide transfer from lysosomes--the missing link in molecular pathology of glucosylceramidase deficiency: a hypothesis based on existing data.

Authors:  M Elleder
Journal:  J Inherit Metab Dis       Date:  2006-11-02       Impact factor: 4.982

4.  Murine models of acute neuronopathic Gaucher disease.

Authors:  Ida Berglin Enquist; Christophe Lo Bianco; Andreas Ooka; Eva Nilsson; Jan-Eric Månsson; Mats Ehinger; Johan Richter; Roscoe O Brady; Deniz Kirik; Stefan Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-22       Impact factor: 11.205

5.  Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration.

Authors:  Tamar Farfel-Becker; Einat B Vitner; Samuel L Kelly; Jessica R Bame; Jingjing Duan; Vera Shinder; Alfred H Merrill; Kostantin Dobrenis; Anthony H Futerman
Journal:  Hum Mol Genet       Date:  2013-09-24       Impact factor: 6.150

Review 6.  Lysosomal storage diseases.

Authors:  Carlos R Ferreira; William A Gahl
Journal:  Transl Sci Rare Dis       Date:  2017-05-25

7.  Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: potential role in neuropathology.

Authors:  Ying Sun; Jane Florer; Christopher N Mayhew; Zhanfeng Jia; Zhiying Zhao; Kui Xu; Huimin Ran; Benjamin Liou; Wujuan Zhang; Kenneth D R Setchell; Jianguo Gu; Gregory A Grabowski
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

8.  Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits.

Authors:  Ying Sun; Benjamin Liou; Huimin Ran; Matthew R Skelton; Michael T Williams; Charles V Vorhees; Kazuyuki Kitatani; Yusuf A Hannun; David P Witte; You-Hai Xu; Gregory A Grabowski
Journal:  Hum Mol Genet       Date:  2010-01-04       Impact factor: 6.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.